TORONTO, April 19, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
More than 525 people from 34 states and two countries, each of whom are somehow connected to a person with profound autism, united together at a first-of-its-kind summit in Brighton. And Profound ...
61% were treated for prostate cancer only, 28% were hybrid patients suffering from both prostate cancer and benign prostatic hyperplasia (“BPH”), 10% were salvage, and 1% were men with BPH only; For ...
TORONTO, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable ...
NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Profound today announced it has reached $1 billion in valuation and raised a $96 million Series C led by Lightspeed Venture Partners. Existing investors ...
Hosted on MSN
Profound Medical outlines path to $85M revenue and profitable growth with TULSA expansion in 2026
Earnings Call Insights: Profound Medical Corp. (PRN:CA) Q4 2025 Arun Menawat, Chairman & CEO, emphasized the completion of recruitment for CAPTAIN, the first multicenter, randomized, controlled trial ...
Profound Medical (PROF Quick Quote PROF - Free Report) shares soared 9.5% in the last trading session to close at $8.34. The move was backed by solid volume with far more shares changing hands than in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results